Ashland Inc.
As of Oct 22, 2026, Ashland is in Stage 2, the uptrend phase, now in week 20 (since Jun 3, 2026). It closed at $73.57, 3.2% below its 52-week high and above its 200-day average, which is rising.
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 19 in Specialty Chemicals · #1 of 76 in Materials
Is ASH early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
ASH among Specialty Chemicals6th of 62 by relative strength
All 62 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | SSL | Stage 2 · wk 7 | 98 | +22.2% |
| 2 | ALTO | Stage 4 · wk 4 | 98 | −3.8% |
| 3 | CLMT | Stage 2 · wk 58 | 97 | −9.3% |
| 4 | KRO | Stage 2 · wk 10 | 90 | −9.4% |
| 5 | LYB | Stage 2 · wk 7 | 87 | +9.0% |
| 6 | ASH | Stage 2 · wk 20 | 86 | +6.6% |
| 7 | IFF | Stage 2 · wk 21 | 85 | +9.5% |
| 8 | KOP | Stage 3 · wk 4 | 85 | −11.9% |
Ashland: quick answers
What stage is Ashland in?
As of Oct 22, 2026, Ashland (ASH) is in Stage 2, the uptrend phase. It entered Stage 2 on Jun 3, 2026 and is in week 20. What the four stages mean
Is Ashland in an uptrend?
Yes. Ashland is in a Stage 2 uptrend. It trades 17.1% above its 200-day average, which is rising.
How far is Ashland from its 52-week high?
Ashland closed at $73.57 on Oct 22, 2026, 3.2% below its 52-week high of $76.01. Its 52-week low is $46.54.
How has Ashland performed over the past year?
As of Oct 22, 2026, Ashland is up 49.3% over the past year and up 25.4% so far in 2026.
Which sector and industry is Ashland in?
Ashland is in the Specialty Chemicals industry, part of the Materials sector.
About this companyMaterials· Specialty Chemicals
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.